Cargando…

THE IMPACT OF ORAL ANTICOAGULANTS ON THE OUTCOMES OF COVID-19 PATIENTS WITH A HISTORY OF HF AND ATRIAL FIBRILLATION

Detalles Bibliográficos
Autores principales:	Zadeh, Ali Vaeli, Wong, Alan, Zachariah, Ashvin, Collado, Jose, Larned, Joshua M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972431/ http://dx.doi.org/10.1016/S0735-1097(22)03133-3

Ejemplares similares

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

IMPACT OF OACS ON OUTCOMES OF COVID-19 INFECTION IN OLDER ADULTS WITH HISTORY OF ATRIAL FIBRILLATION
por: Carrero, Ricardo Criado, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

RISK OF HEART FAILURE AFTER CATHETER ABLATION VS. MEDICAL THERAPY FOR ATRIAL FIBRILLATION IN OLDER ADULTS
por: Carrero, Ricardo Criado, et al.
Publicado: (2022)

ORAL ANTICOAGULATION IN HOSPITALIZED PATIENTS WITH COVID-19, IS IT BENEFICIAL OR HARMFUL ?
por: Gade, Akhil Reddy, et al.
Publicado: (2022)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

ATRIAL FIBRILLATION IS ASSOCIATED WITH EARLY MORTALITY IN CRITICALLY ILL PATIENTS WITH COVID-19
por: Foster, Michael W., et al.
Publicado: (2022)

SEVERITY OF COVID-19 FURTHER INCREASES THE ODDS OF NEW-ONSET ATRIAL FIBRILLATION AND FLUTTER
por: Shah, Paras P., et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND CHRONIC KIDNEY DISEASE
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
por: Patel, Aman, et al.
Publicado: (2022)

NEW-ONSET ATRIAL FIBRILLATION DURING HOSPITALIZATION FOR COVID-19 PATIENTS WITHOUT PREEXISTING CARDIOVASCULAR DISEASE
por: Wang, Suwei, et al.
Publicado: (2021)

IMPACT OF ATRIAL FIBRILLATION IN A PATIENT ADMITTED WITH COVID-19 INFECTION: A NATIONWIDE SAMPLE ANALYSIS
por: Ellis, John, et al.
Publicado: (2023)

Myocarditis And COVID-19: An Analysis Of All Claims Administrative Data From Before And During The Pandemic
por: Zadeh, Ali Vaeli, et al.
Publicado: (2023)

Comorbidities Associated With Myocarditis In Hospitalized COVID-19 Patients
por: Zadeh, Ali Vaeli, et al.
Publicado: (2023)

THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND DIABETES
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

FREQUENT CAUSES OF 30-DAY READMISSION FOLLOWING A FIRST EPISODE OF HEART FAILURE IN OLDER ADULTS
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

TRENDS OF ANTICOAGULATION UTILIZATION IN COVID-19: RESULTS FROM A NATIONAL ELECTRONIC HEALTH RECORD-DERIVED COHORT
por: Kolkailah, Ahmed A., et al.
Publicado: (2022)

EFFECT OF ASPIRIN IN COVID-19 OUTCOMES OF OLDER ADULTS WITH A HISTORY OF CORONARY ARTERY DISEASE
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

ATRIAL ARRHYTHMIAS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19
por: Bailey, Som Aftabi, et al.
Publicado: (2021)

CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
por: Siddiqi, Hasan, et al.
Publicado: (2021)

RISK OF RECURRENT MYOCARDITIS FOLLOWING COVID-19 MRNA VACCINATION IN ADULTS WITH PRIOR HISTORY
por: Simone, Anthony, et al.
Publicado: (2022)

CLINICAL AND ECONOMIC OUTCOMES OF PHARMACOLOGICAL STRESS TESTS IN PATIENTS WITH A HISTORY OF COVID-19
por: Skali, Hicham, et al.
Publicado: (2022)

THE CLINICAL COURSE OF PATIENTS WITH A HISTORY OF ACUTE PERICARDITIS FOLLOWING VACCINATION AGAINST SARS-COV2
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

Growing thrombus adhesion on the left atrial wall after catheter ablation of atrial fibrillation
por: Kawaji, Tetsuma, et al.
Publicado: (2023)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

Inappropriate mode switch and unwarranted right ventricular pacing during atrial fibrillation: Paradoxical atrial undersensing
por: Hayashi, Katsuhide, et al.
Publicado: (2022)

APABETALONE (RVX-208) REDUCES ACE2 PROTEIN ABUNDANCE AND PREVENTS SARS-COV-2 SPIKE PROTEIN BINDING TO HUMAN LUNG CELLS, A MOA THAT COULD ATTENUATE VIRAL ENTRY
por: Fu, Li, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

COVID-19 OUTCOMES AND CLINICAL CORRELATION WITH MYOCARDIAL INJURY ON ADMISSION TO HOSPITAL
por: Manmathan, Gavin, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

STRESS-INDUCED CARDIOMYOPATHY IN A PANDEMIC YEAR
por: Cundiff, Michael, et al.
Publicado: (2021)

HYPERDYNAMIC LEFT VENTRICULAR EJECTION FRACTION IS A POOR PROGNOSTIC SIGN IN COVID-19 INFECTION
por: Ruge, Max, et al.
Publicado: (2021)

INCIDENCE OF MAJOR ADVERSE CARDIAC EVENTS AT 6-MONTHS FOLLOW-UP IN COVID-19 POSITIVE VERSUS COVID-19 NEGATIVE PATIENTS
por: Arman, Huseyin Emre, et al.
Publicado: (2023)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_opkhr0e1mjac8a8rb9nac6ksn3